We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Details How to Submit BLA Post-Approval Reporting Changes
FDA Details How to Submit BLA Post-Approval Reporting Changes
All post-approval changes to a Biologics License Application (BLA) should be submitted based on three categories organized by risks to safety and efficacy, the FDA said in a final guidance released yesterday.